Beijing,China–July30,2025–WecareProbioticsannouncedthesuccessfulconclusionofitspivotalseminar,"ClinicallyValidated+PotencyGuaranteed+OfficiallyRegistered:DrivingProbioticProductsBacktoFundamentals."TheeventspecificallyhighlightedthegroundbreakinginclusionintotheInfantFoodWhitelistoftheBLa80strain.BL

Ulcerativecolitis(UC)isalifelongconditionmarkedbypainfulflares,limiteddrugoptions,andagutmicrobiotaindisarray.This21-daytrialsetouttotestwhetheradailydoseofLactobacillusacidophilusLA85coulddelivermeasurablereliefintheDSStreatedmousemodelwithUC.Itssignificanceliesinthreeclearoutcomes:1.CalmerDigestio

WecareProbiotics'Bifidobacteriumanimalissubsp.lactisBLa80hasmadehistoryasthefirstprobioticstrainfrommainlandChinatoentertheInfantWhitelistwithbothself-affirmedGRASandFDAGRASstatus.Here'showWecarebuiltanironcladsafetyfortressforBLa80:GRAS:TheGoldStandardofSafetyGRASstatus,governedbytheFDA,mar

Theglobalhealthlandscapeisundergoingasignificanttransformation,markedbyadramaticincreaseinoverweightandobesityrates.AccordingtotheWorldHealthOrganization(WHO),in2025thisyear,astaggeringoneineightpeopleworldwidewerelivingwithobesity.Inthiscontext,scientificresearchiscontinuouslyexploringnovelapproach

Suzhou,China–July20,2025–WecareProbioticsannouncedalandmarkstrategicpartnershipwithDassaultSystèmes,theworldleaderinProductLifecycleManagement(PLM)solutions.TheofficialsigningceremonyonJuly20,2025,marksasignificantmilestoneinWecare'journeytowardadvanceddigitalizationandsustainablegrowth.Thiscoll

WecareProbiotics,asaleadingtechnologicalinnovator,isexcitedtoannouncethesignificantpotentialofitsflagshipprobioticstrain,LacticaseibacillusRhamnosusLRa05,inadvancingwomen'shealth.Withrobustresearchsupportingitssafetyandefficacy,LRa05ispoisedtobecomeacornerstoneinfemalewell-being.Originallyderive